← Back to Clinical Trials
Recruiting Phase 2, Phase 3 NCT06899841
Dexmedetomidine in Sonographic Guided Erector Spinae Plane Block
Trial Parameters
Condition Pain Management
Sponsor Assiut University
Study Type INTERVENTIONAL
Phase Phase 2, Phase 3
Enrollment 90
Sex ALL
Min Age 18 Years
Max Age 70 Years
Start Date 2024-10-01
Completion 2025-10-01
Interventions
Dexmedetomidine
Brief Summary
to investigate the postoperative analgesic effect of dexmedetomidine addition with different doses as an adjuvant to bupivacaine to Erector spinae plane block after renal surgeries.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 70 years. * Both sexes, males and females. * Patients with the American Society of Anesthesiologists (ASA) physical status I/II. * Body mass index (BMI) of 18-35 kg/m2 * Patients scheduled for elective Renal or Percutaneous Nephrolithotomy. Exclusion Criteria: * Patients under 18 years. * Patient refusal of nerve block. * Infection at the site of injection. * Coagulopathy. * Allergy to used medications. * Psychiatric disorder or chronic pain syndromes. * Chronic opioid use or substance abuse. * Quadriplegic patients.
Related Trials
NCT07311902
M-Tapa Block and Transversus Abdominal Plane Block for Postoperative Analgesia in Unilateral Open In
View Trial →
NCT07423650
Continous Infusion of Nefopam for Patients Undergoing Pancreatoduodenectomy
View Trial →
NCT07396753
The Effects of Transversalis Fascia Plane Block on Opioid Consumption in Patients Undergoing Hand-As
View Trial →